The current price is because of the potential in C
Post# of 148172
It has the potential to be our first revenue generator.
COVID has slowed down all of our other trials, so it's hard to know where we would be today. I suspect that we would be somewhat further along in cancer trials for example. But I think the share price would likely be lower than it is currently.
At the end of the day, this is where we are at. Fingers crossed that the data is as strong as it appears to be.